Wahood Waseem, Takahashi Edwin, Rajan Dheeraj, Misra Sanjay
Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, Florida, USA.
Department of Interventional Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Kidney Int Rep. 2023 Mar 20;8(6):1162-1169. doi: 10.1016/j.ekir.2023.03.001. eCollection 2023 Jun.
The aim of this study is to assess the trends in access-related complications, as well as the impact of race on these complications, among admitted patients with end-stage kidney disease (ESKD) receiving hemodialysis.
A retrospective cohort study between 2005 and 2018 was performed using the National Inpatient Sample (NIS). Hospitalizations involving ESKD and hemodialysis were identified. There were 9,246,553 total admissions involving ESKD and hemodialysis, of which 1,167,886 (12.6%) had complications. Trends in complications were assessed and compared among races.
There was a decreasing trend in rates of mechanical (trend: -0.05% per year; < 0.001), inflammatory or infectious (-0.48%; < 0.001), and other (-0.19%; < 0.001) complications from 2005 to 2018. Non-White patients had a greater magnitude in the decrease in trends in rates of complications compared to White patients (-0.69% per year vs. -0.57%; < 0.001). Compared to the White patients, Black patients (odds ratio [OR]: 1.26; < 0.001) and those of the other races (OR: 1.11; < 0.001) had higher odds of complications. These differences were also statistically significant among lower socioeconomic classes (75 percentile vs. 0-25 percentile: = 0.009) and within southern states (vs. Northeast: < 0.001).
Although there was an overall decrease in the trends of dialysis-associated complications requiring hospitalization among ESKD patients receiving hemodialysis, non-White patients have higher odds of complications compared to White patients. The findings in this study emphasize the need for more equitable care for hemodialysis patients.
本研究旨在评估接受血液透析的终末期肾病(ESKD)住院患者中与血管通路相关并发症的趋势,以及种族对这些并发症的影响。
利用全国住院患者样本(NIS)进行了一项2005年至2018年的回顾性队列研究。确定了涉及ESKD和血液透析的住院病例。总共有9246553例涉及ESKD和血液透析的入院病例,其中1167886例(12.6%)出现并发症。评估并比较了各种族并发症的趋势。
2005年至2018年期间,机械性并发症(趋势:每年-0.05%;P<0.001)、炎症或感染性并发症(-0.48%;P<0.001)以及其他并发症(-0.19%;P<0.001)的发生率呈下降趋势。与白人患者相比,非白人患者并发症发生率下降趋势的幅度更大(每年-0.69%对-0.57%;P<0.001)。与白人患者相比,黑人患者(优势比[OR]:1.26;P<0.001)和其他种族患者(OR:1.11;P<0.001)发生并发症的几率更高。这些差异在社会经济地位较低的阶层中(第75百分位数与第0-25百分位数:P=0.009)以及南部各州内(与东北部相比:P<0.001)也具有统计学意义。
尽管接受血液透析的ESKD患者中需要住院治疗的透析相关并发症总体呈下降趋势,但与白人患者相比,非白人患者发生并发症的几率更高。本研究结果强调了为血液透析患者提供更公平护理的必要性。